Lys25
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Acetylation Site Page:
Lys25 - ACAA2 (human)

Site Information
GAYGGLLkDFTATDL   SwissProt Entrez-Gene
Predicted information:  Scansite
Orthologous residues: ACAA2 (mouse): K25, ACAA2 (rat): K25
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 461222

In vivo Characterization
Methods used to characterize site in vivo: mass spectrometry (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
Disease tissue studied: liver cancer (14, 15), hepatocellular carcinoma (14, 15), lung cancer (1), non-small cell lung adenocarcinoma (1)
Relevant cell line - cell type - tissue: A549 (pulmonary) (1, 4), HeLa (cervical) (2), HepG2 (hepatic) (14, 15), Jurkat (T lymphocyte) (4), liver (3), OCI-ly3 (B lymphocyte) (8, 10, 12, 13), RC-K8 (B lymphocyte) (9, 11), Reh (B lymphocyte) (5, 6, 7)




References

1

Wu Q, et al. (2015) Suberoylanilide hydroxamic acid treatment reveals crosstalks among proteome, ubiquitylome and acetylome in non-small cell lung cancer A549 cell line. Sci Rep 5, 9520
25825284   Curated Info

2

Weinert BT, et al. (2013) Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep 4, 842-51
23954790   Curated Info

3

Zhao S, et al. (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-4
20167786   Curated Info

4

Choudhary C, et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-40
19608861   Curated Info

5

(2007) CST Curation Set: 2707; Year: 2007; Biosample/Treatment: cell line, Reh/DMSO; Disease: acute lymphocytic leukemia; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

6

(2007) CST Curation Set: 2708; Year: 2007; Biosample/Treatment: cell line, Reh/SAHA 3h; Disease: acute lymphocytic leukemia; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

7

(2007) CST Curation Set: 2709; Year: 2007; Biosample/Treatment: cell line, Reh/SAHA 6h; Disease: acute lymphocytic leukemia; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

8

(2007) CST Curation Set: 2510; Year: 2007; Biosample/Treatment: cell line, OCI-ly3/DMSO; Disease: B cell lymphoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

9

(2007) CST Curation Set: 2436; Year: 2007; Biosample/Treatment: cell line, RC-K8/DMSO; Disease: B cell lymphoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

10

(2007) CST Curation Set: 2437; Year: 2007; Biosample/Treatment: cell line, OCI-ly3/DMSO; Disease: B cell lymphoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

11

(2007) CST Curation Set: 2438; Year: 2007; Biosample/Treatment: cell line, RC-K8/SAHA 3h; Disease: B cell lymphoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

12

(2007) CST Curation Set: 2440; Year: 2007; Biosample/Treatment: cell line, OCI-ly3/SAHA 3h; Disease: B cell lymphoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

13

(2007) CST Curation Set: 2441; Year: 2007; Biosample/Treatment: cell line, OCI-ly3/SAHA 6h; Disease: B cell lymphoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

14

(2005) CST Curation Set: 868; Year: 2005; Biosample/Treatment: cell line, HepG2/TSA; Disease: hepatocellular carcinoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

15

(2005) CST Curation Set: 869; Year: 2005; Biosample/Treatment: cell line, HepG2/TSA; Disease: hepatocellular carcinoma; SILAC: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.